BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33469693)

  • 1. Comparative evaluation of intracranial oligodendroglioma and astrocytoma of similar grades using conventional and T1-weighted DCE-MRI.
    Gupta M; Gupta A; Yadav V; Parvaze SP; Singh A; Saini J; Patir R; Vaishya S; Ahlawat S; Gupta RK
    Neuroradiology; 2021 Aug; 63(8):1227-1239. PubMed ID: 33469693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
    Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
    Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma grading using a machine-learning framework based on optimized features obtained from T
    Sengupta A; Ramaniharan AK; Gupta RK; Agarwal S; Singh A
    J Magn Reson Imaging; 2019 Oct; 50(4):1295-1306. PubMed ID: 30895704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.
    Zhang S; Chiang GC; Magge RS; Fine HA; Ramakrishna R; Chang EW; Pulisetty T; Wang Y; Zhu W; Kovanlikaya I
    Magn Reson Imaging; 2019 Apr; 57():254-258. PubMed ID: 30465868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
    Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR textural analysis on T
    Rui W; Ren Y; Wang Y; Gao X; Xu X; Yao Z
    J Magn Reson Imaging; 2018 Jul; 48(1):74-83. PubMed ID: 29140606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images.
    Sengupta A; Agarwal S; Gupta PK; Ahlawat S; Patir R; Gupta RK; Singh A
    Eur J Radiol; 2018 Sep; 106():199-208. PubMed ID: 30150045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
    Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A
    Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
    Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
    J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
    Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
    J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.
    Nam YK; Park JE; Park SY; Lee M; Kim M; Nam SJ; Kim HS
    Eur Radiol; 2021 Oct; 31(10):7374-7385. PubMed ID: 34374800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.
    Yeniçeri İÖ; Yıldız ME; Özduman K; Danyeli AE; Pamir MN; Dinçer A
    Diagn Interv Radiol; 2021 Nov; 27(6):796-801. PubMed ID: 34792037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning predicts histologic type and grade of canine gliomas based on MRI texture analysis.
    Barge P; Oevermann A; Maiolini A; Durand A
    Vet Radiol Ultrasound; 2023 Jul; 64(4):724-732. PubMed ID: 37133981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes.
    Guo H; Kang H; Tong H; Du X; Liu H; Tan Y; Yang Y; Wang S; Zhang W
    Eur Radiol; 2019 Apr; 29(4):1893-1902. PubMed ID: 30276676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Pilocytic Astrocytoma from Glioblastoma using a Machine-Learning framework based upon quantitative T1 perfusion MRI.
    Vats N; Sengupta A; Gupta RK; Patir R; Vaishya S; Ahlawat S; Saini J; Agarwal S; Singh A
    Magn Reson Imaging; 2023 May; 98():76-82. PubMed ID: 36572323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DCE-MRI in Human Gliomas: A Surrogate for Assessment of Invasive Hypoxia Marker HIF-1Α Based on MRI-Neuronavigation Stereotactic Biopsies.
    Xie Q; Wu J; Du Z; Di N; Yan R; Pang H; Jin T; Zhang H; Wu Y; Zhang Y; Yao Z; Feng X
    Acad Radiol; 2019 Feb; 26(2):179-187. PubMed ID: 29754996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma.
    Sanz-Requena R; Revert-Ventura AJ; García-Martí G; Salamé-Gamarra F; Pérez-Girbés A; Mollá-Olmos E; Martí-Bonmatí L
    Eur Radiol; 2017 Aug; 27(8):3392-3400. PubMed ID: 27999986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
    You SH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST; Choi HJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    Radiology; 2018 Mar; 286(3):981-991. PubMed ID: 29244617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.
    Zhao K; Sun G; Wang Q; Xue Z; Liu G; Xia Y; Yao A; Zhao Y; You N; Yang C; Xu B
    Acad Radiol; 2021 Jul; 28(7):e189-e198. PubMed ID: 32359929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.
    Corell A; Ferreyra Vega S; Hoefling N; Carstam L; Smits A; Olsson Bontell T; Björkman-Burtscher IM; Carén H; Jakola AS
    BMC Cancer; 2020 May; 20(1):450. PubMed ID: 32434559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.